Jeffrey Robert Ajer - 07 Apr 2025 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
Issuer symbol
VRDN
Transactions as of
07 Apr 2025
Net transactions value
$0
Form type
3
Filing time
09 Apr 2025, 16:19:55 UTC
Previous filing
17 Jan 2025
Next filing
02 Jul 2025

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney